Skip to main content
. 2017 Dec;45:278–286. doi: 10.1016/j.tiv.2017.09.010

Table 2.

Category designation by sponsors and Drug Regulatory Agencies for Carcinogenicity Assessment Documents (adapted from (ICH, 2016)).

Categories Sponsor DRAs
Category 1 2 1
Category 2 7 15
Category 3a 8 5
Category 3b 8 1
Partial DRA alignment 0 3